Mr. John Moir, United Kingdom
Incidence of de-novo donor specific anti-human leucocyte antigen (HLA antibodies (DSA) in simultaneous pancreas kidney (SPK) transplant patients: A comparison between alemtuzumab and basiliximab based immunosuppression regimes